- Sections
- C - Chimie; métallurgie
- C12N - Micro-organismes ou enzymes; compositions les contenant; culture ou conservation de micro-organismes; techniques de mutation ou de génétique; milieux de culture
- C12N 15/24 - Interleukines
Détention brevets de la classe C12N 15/24
Brevets de cette classe: 295
Historique des publications depuis 10 ans
12
|
15
|
8
|
13
|
17
|
17
|
25
|
21
|
24
|
6
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
ZymoGenetics, Inc. | 244 |
14 |
ZymoGenetics, LLC | 20 |
10 |
The Trustees of the University of Pennsylvania | 4122 |
6 |
Regeneron Pharmaceuticals, Inc. | 3650 |
6 |
Altor BioScience, LLC | 63 |
6 |
Joint Stock Company "BIOCAD" | 157 |
5 |
National University of Singapore | 2228 |
5 |
Noile-immune Biotech Inc. | 31 |
5 |
Merck Patent GmbH | 5909 |
4 |
National University Corporation Tottori University | 193 |
4 |
Ottawa Hospital Research Institute | 102 |
4 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
4 |
University Health Network | 979 |
4 |
Yale University | 2204 |
4 |
Nanjing Bioheng Biotech Co., Ltd | 40 |
4 |
Turnstone Biologics Corp. | 12 |
4 |
Novartis AG | 11238 |
3 |
Boehringer Ingelheim International GmbH | 4629 |
3 |
Children's Healthcare of Atlanta, Inc. | 231 |
3 |
Cytheris | 4 |
3 |
Autres propriétaires | 194 |